We’re called Q’Apel for the Qu’Appelle River, a waterway that winds through Saskatchewan, Canada. Why? Because this pristine river charts a winding path, full of twists, turns, and straightaways alike. That’s what we do, too. Our cutting-edge products—neurological catheters, specifically—are designed to navigate the twists and turns of the brain’s neurovasculature, empowering therapeutic thrombectomy and cerebral aneurysm devices to deliver life-changing outcomes.Who We Are
Amy has 13 years of medical device experience bringing disruptive interventional technologies to market and joined Q’Apel Medical in 2019. Amy has held marketing, sales, and business development roles at both start-up companies as well as Fortune 500. She began her medical device career in the international markets at Device Technologies Australia, focused on their interventional portfolio, specializing in neurovascular (Codman Neurovascular & Mindframe, Inc.-acquired by Covidien) and peripheral vascular (IDEV Technologies- acquired by Abbott). Upon returning to the US, Amy held roles in international product marketing and US field sales in the neuro and peripheral vascular specialties (Covidien/Medtronic). More recently, Amy has established Sales & Marketing strategies for various startup companies as a consultant.
By working side by side with neurological specialists and caregivers, we craft solutions that get straight to the heart of what’s needed. Reach out to learn more.